Evidence map›Paper›PMID 28842424›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.

Jianghong Cheng, Yanhong Zhong, Shuai Chen, Yan Sun, Lantang Huang, Yujia Kang, Baozhen Chen, Gang Chen, Fengli Wang, Yingpu Tian and 3 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jianghong ChengSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Yanhong ZhongSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Shuai ChenSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Yan SunSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Lantang HuangSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Yujia KangSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Baozhen ChenDepartment of Pathology, Fujian Provincial Tumor Hospital, Fuzhou, China.
Gang ChenDepartment of Pathology, Fujian Provincial Tumor Hospital, Fuzhou, China.
Fengli WangSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Yingpu TianSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Wenjie LiuSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Gen-Sheng FengDivision of Biological Sciences, Department of Pathology, University of California, San Diego, La Jolla, California, USA.
Zhongxian LuSchool of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China; zhongxian@xmu.edu.cn.
Xiamen University · CNFujian Provincial Cancer Hospital · CNUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our previous studies have found that Growth factor receptor-bound protein 2-associated binding protein 2 (Gab2)-a docking protein-governs the development of fatty liver disease. Here, we further demonstrate that Gab2 mediates hepatocarcinogenesis. Compared with a faint expression in

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosisBlotting, WesternCarcinoma, HepatocellularCell MovementDiethylnitrosamineEnzyme-Linked Immunosorbent AssayGene Expression Regulation, NeoplasticHep G2 CellsHumansLiver NeoplasmsMiceMice, Inbred C57BLMice, NudeSignal TransductionAdaptor Proteins, Signal TransducingDiethylnitrosamineGAB2 protein, humanHCCIL-6Jak2/Stat3 signaling pathwayknockout mousetherapeutic target

Identifiers

PMID28842424
PMCPMC5690380
OpenAlexW2749732480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.